HRT solutions for Women with Comorbidities
Overview
How can we safely navigate discussions about HRT for menopausal women with comorbidities?
Dr. Spencer Kellogg, board certified OB/GYN with 40+ years’ experience in women’s health discusses the risks, benefits, efficacy, and safety of customized hormone therapy to manage menopausal symptoms in women with comorbid conditions (CV risk, obesity, breast cancer, cognition) and those with increased risk of developing comorbidities and applies them to a real-life case study.
Intended audience
- Pharmacists & Pharmacy Technicians
Hardware/software requirements
We will be using Zoom for this webinar - full system requirements can be found here. You can download the Zoom client here.
| Web browser |
| ||
Internet connection |
| ||
Misc |
| ||
Hardware | Minimum | Recommended | |
| Processor | Single-core 1Ghz or higher | Dual-core 2Ghz or higher (Intel i3/i5/i7 or AMD equivalent) | |
| RAM | N/A | 4 GB | |
COPYRIGHT
This webinar is Copyright © 2026 LP3 Network
| Dr. Spencer Kellogg, MD | ![]() |
CANCELLATION AND REFUND POLICY
There are no refunds, returns or transfers upon purchase of the webinar.

Facebook
X
LinkedIn
Forward